Texas House of Representatives · 89th Legislature, Regular Session
Official title: Relating to the establishment of the sickle cell disease registry.
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)89R
House Bill 107 adds Chapter 52B to the Health and Safety Code and directs the department to establish and maintain a sickle cell disease registry, which the bill describes as a single repository of accurate, complete records of sickle cell disease cases to aid in the cure and treatment of sickle cell disease in this state. The bill defines a "health care facility" as a hospital licensed under Chapter 241 or any other facility that provides diagnostic or treatment services to patients with sickle cell disease, and it requires each such facility to provide the department data the department considers necessary concerning sickle cell disease cases. The executive commissioner shall adopt rules to implement the chapter and shall develop guidelines that require the consent of an individual, or the individual's legally authorized representative, before that individual's information is included in the registry, and that allow consent to be withdrawn. Under Section 52B.005, reports, records, and information obtained under the chapter are not public information, are not subject to Chapter 552, Government Code, and are not subject to subpoena, and they may be released only as the chapter provides. The department's institutional review board established under Chapter 108 shall review and approve requests for access to information that identifies individuals in the registry. The department shall submit an annual report to the legislature on the information obtained under the chapter. The bill states that the Department of State Health Services is required to implement a provision only if the legislature appropriates money specifically for that purpose, and if the legislature does not, the department may, but is not required to, implement it using other money available for that purpose. This Act takes effect September 1, 2025.
Read the full text below for the definitive meaning.
Taller bars are bigger costs to the fund (money out). A bar below the line, marked with a plus, is a gain (money in).
| Fiscal year | Cost to General Revenue-Related Funds |
|---|---|
| 2026 | $3,346,894 |
| 2027 | $1,448,477 |
| 2028 | $747,954 |
| 2029 | $748,869 |
| 2030 | $749,804 |
Methodology: The analysis assumes DSHS would require 5.0 additional full-time-equivalent positions (FTEs) to establish and maintain the registry. This includes 2.0 FTE Epidemiologist III positions to calculate appropriate statistics, to analyze data quality, and to create reports; a 1.0 FTE Information Specialist IV position to oversee the dissemination of data and reports from the Sickle Cell Registry and to conduct trainings and education for registry users; a 1.0 FTE Program Specialist V position to oversee the Sickle Cell Registry Program and serve as the subject matter expert; and a 1.0 FTE Systems Analyst V position for programming, quality assurance testing, managing system specifications and requirements, and security and updates on the new Sickle Cell Disease Registry system. Salaries, benefits, and other related costs for the new FTEs total $531,242 in fiscal year 2026 and $746,854 in fiscal year 2027, all from the General Revenue Fund. The lower cost in fiscal year 2026 is attributable to a later start date for the new positions assumed in the first fiscal year and because the Systems Analyst V position would begin as a 0.5 FTE in fiscal year 2026. Local Government Impact: No significant fiscal implication to units of local government is anticipated.
Source: Legislative Budget Board fiscal note, prepared with the Health And Human Services Commission. Read the full fiscal note
Each version links to the authoritative document on capitol.texas.gov.
H.B. No. 107 AN ACT relating to the establishment of the sickle cell disease registry. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subtitle B, Title 2, Health and Safety Code, is amended by adding Chapter 52B to read as follows: CHAPTER 52B. SICKLE CELL DISEASE REGISTRY Sec. 52B.001. DEFINITION. In this chapter, "health care facility" means: (1) a hospital licensed under Chapter 241; or
Statewide figures for the subjects tagged on this bill, to explore on the Data map. They describe Texas — not this bill or its effects.
SourceU.S. Census Bureau (ACS) & CDC PLACESstatewide Data layer
Each subject links to other 89R bills tagged the same way.
(2) any other facility that provides diagnostic or treatment services to patients with sickle cell disease. Sec. 52B.002. REGISTRY; CONTENTS. (a) The department shall establish and maintain a sickle cell disease registry in accordance with this chapter for use as a single repository of accurate, complete records of sickle cell disease cases to aid in the cure and treatment of sickle cell disease in this state. (b) The sickle cell disease registry must include: (1) a record of sickle cell disease cases that occur in this state; and (2) any other information concerning sickle cell disease cases the executive commissioner considers necessary and appropriate to assist with the cure or treatment of sickle cell disease. Sec. 52B.003. DATA FROM HEALTH CARE FACILITIES. A health care facility shall provide to the department, in the form and manner the department prescribes, data the department considers necessary and appropriate concerning sickle cell disease cases. Sec. 52B.004. DEPARTMENT POWERS; RULES. (a) To implement this chapter, the department may: (1) execute necessary contracts; (2) receive data from health care facilities concerning sickle cell disease cases to record and analyze the data directly related to the disease; and (3) compile and publish statistical and other studies derived from data obtained under this chapter to provide, in an accessible form, information useful to physicians, other medical personnel, and the public. (b) The executive commissioner shall adopt rules to implement this chapter. (c) The executive commissioner by rule shall develop guidelines to: (1) obtain data from health care facilities regarding sickle cell disease cases; (2) require consent of an individual or the individual's legally authorized representative before any information relating to the individual is included in the sickle cell disease registry; (3) allow the individual or the individual's legally authorized representative to withdraw consent for inclusion of the individual's information in the registry; (4) protect the confidentiality of individuals diagnosed with sickle cell disease in accordance with Section 159.002, Occupations Code; and (5) ensure the registry is developed in a manner consistent with: (A) the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191) and regulations adopted under that Act; and (B) other applicable laws and rules governing the disclosure of health information. (d) The executive commissioner shall ensure the rules adopted under this section provide protections to restrict the use or disclosure of Medicaid information to purposes only directly connected with the administration of the Medicaid program. Sec. 52B.005. CONFIDENTIALITY. (a) Reports, records, and information obtained under this chapter: (1) are not public information; (2) are not subject to the requirements of Chapter 552, Government Code; (3) are not subject to subpoena; and (4) may not otherwise be released or made public except as provided by this section or Section 52B.004. (b) The reports, records, and information obtained under this chapter are for the confidential use of the department and the persons or public or private entities the department determines are necessary to carry out the purposes of this chapter. (c) Medical or epidemiological information may be released: (1) for statistical purposes in a manner that prevents identification of individuals, health care facilities, clinical laboratories, or health care practitioners; or (2) with the consent of each person identified in the information. (d) A state employee may not testify in a civil, criminal, special, or other proceeding as to the existence or contents of records, reports, or information concerning an individual's medical records used in submitting information required under this chapter unless the individual consents in advance. (e) Information furnished to a sickle cell disease registry or a sickle cell researcher under Subsection (c) is for the confidential use of the sickle cell disease registry or the sickle cell researcher, as applicable, and is subject to Subsection (a). (f) The department's institutional review board established under Chapter 108 shall review and approve requests for access to information that identifies individuals in the sickle cell disease registry. Sec. 52B.006. REPORTS. (a) The department shall submit an annual report to the legislature on the information obtained under this chapter. (b) The department, in cooperation with other sickle cell disease reporting organizations and research institutions, may publish reports the department determines are necessary to carry out the purposes of this chapter. SECTION 2. The Department of State Health Services is required to implement a provision of this Act only if the legislature appropriates money specifically for that purpose. If the legislature does not appropriate money specifically for that purpose, the department may, but is not required to, implement a provision of this Act using other money available for that purpose. SECTION 3. As soon as practicable after the effective date of this Act, the executive commissioner of the Health and Human Services Commission shall adopt rules necessary to implement Chapter 52B, Health and Safety Code, as added by this Act. SECTION 4. This Act takes effect September 1, 2025. ______________________________ ______________________________ President of the Senate Speaker of the House I certify that H.B. No. 107 was passed by the House on April 28, 2025, by the following vote: Yeas 110, Nays 33, 1 present, not voting; and that the House concurred in Senate amendments to H.B. No. 107 on May 28, 2025, by the following vote: Yeas 96, Nays 31, 2 present, not voting. ______________________________ Chief Clerk of the House I certify that H.B. No. 107 was passed by the Senate, with amendments, on May 20, 2025, by the following vote: Yeas 25, Nays 6. ______________________________ Secretary of the Senate APPROVED: __________________ Date __________________ Governor
SourceTexas Legislative Council (capitol.texas.gov)official bill text (capitol.texas.gov)
SourceLegiScan (CC BY 4.0)subject tags
SourceTexas Legislative Council (capitol.texas.gov)89R
SourceLegiScan (CC BY 4.0)89R
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
Official hearings & comment (capitol.texas.gov) →SourceLegiScan (CC BY 4.0)hearing schedule